Australia markets close in 36 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7700-0.1600 (-5.46%)
At close: 04:00PM EDT
2.7700 0.00 (0.00%)
After hours: 06:45PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-110,559
-110,559
-182,024
-220,683
-227,278
Depreciation & amortisation
2,899
2,899
2,889
3,021
2,847
Stock-based compensation
32,854
32,854
42,980
46,851
50,218
Change in working capital
16,790
16,790
-10,506
-35,079
-13,008
Accounts receivable
-8,088
-8,088
-16,550
6,351
-1,971
Inventory
12,463
12,463
-6,191
-6,477
-16,937
Accounts payable
15
15
-578
3,278
-2,233
Other working capital
-60,334
-60,334
-148,737
-206,376
-191,633
Other non-cash items
339
339
202
904
1,429
Net cash provided by operating activities
-58,789
-58,789
-146,912
-203,354
-184,820
Cash flows from investing activities
Investments in property, plant and equipment
-1,545
-1,545
-1,825
-3,022
-6,813
Purchases of investments
-87,658
-87,658
-145,683
-129,221
-134,007
Sales/maturities of investments
107,185
107,185
143,957
164,940
349,775
Net cash used for investing activities
17,995
17,995
-3,324
32,729
208,955
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
29,755
29,755
75,145
0
0
Net cash used provided by (used for) financing activities
54,107
54,107
75,059
156,028
9,105
Net change in cash
13,313
13,313
-75,177
-14,597
33,240
Cash at beginning of period
15,364
15,364
90,541
105,138
71,898
Cash at end of period
28,677
28,677
15,364
90,541
105,138
Free cash flow
Operating cash flow
-58,789
-58,789
-146,912
-203,354
-184,820
Capital expenditure
-1,545
-1,545
-1,825
-3,022
-6,813
Free cash flow
-60,334
-60,334
-148,737
-206,376
-191,633